PEPTIDE VACCINATION AGAINST CANCER TESTIS ANTIGENS IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA: AN ONGOING PHASE I STUDY

被引：0
|
作者：
Holmberg, S. [1 ]
Gang, A. Ortved [1 ]
Svane, I. M. [2 ]
Dufva, I. Hogh [1 ]
Hadrup, S. Reker [3 ]
机构：
[1] Herlev Hosp, Dept Hematol, Herlev, Denmark
[2] Herlev Hosp, Ctr Canc Immune Therapy, Herlev, Denmark
[3] Tech Univ Denmark, Sect Vaccinol & Immunol, Copenhagen, Denmark
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1915
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [41] Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
    Prebet, Thomas
    Charbonnier, Aude
    Gelsi-Boyer, Veronique
    Mozziconacci, Marie Joelle
    Blaise, Didier
    Vey, Norbert
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1538 - 1540
  • [42] INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE: RETROSPECTIVE ANALYSIS FROM A SINGLE CENTER
    Binotto, G.
    Quinto, A. M.
    De March, E.
    Lessi, F.
    Castelli, M.
    Nabergoj, M.
    Gianesello, I.
    Pavanello, F.
    Branca, A.
    Zambello, R.
    Adami, F.
    Semenzato, G.
    LEUKEMIA RESEARCH, 2015, 39 : S47 - S47
  • [43] Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
    Strati, Paolo
    Kantarjian, Hagop
    Ravandi, Farhad
    Nazha, Aziz
    Borthakur, Gautam
    Daver, Naval
    Kadia, Tapan
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Konopleva, Marina
    Rajkhowa, Trivikram
    Durand, Menda
    Andreeff, Michael
    Levis, Mark
    Cortes, Jorge
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (04) : 276 - 281
  • [44] Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study
    Al-Ali, Haifa K.
    Jaekel, Nadja
    Junghanss, Christian
    Maschmeyer, Georg
    Krahl, Rainer
    Cross, Michael
    Hoppe, Gisa
    Niederwieser, Dietger
    LEUKEMIA & LYMPHOMA, 2012, 53 (01) : 110 - 117
  • [45] A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure
    Thepot, Sylvain
    Boehrer, Simone
    Seegers, Valerie
    Prebet, Thomas
    Beyne-Rauzy, Odile
    Wattel, Eric
    Delaunay, Jacques
    Raffoux, Emmanuel
    Hunault, Mathilde
    Jourdan, Eric
    Chermat, Fatiha
    Sebert, Marie
    Kroemer, Guido
    Fenaux, Pierre
    Ades, Lionel
    LEUKEMIA RESEARCH, 2014, 38 (12) : 1430 - 1434
  • [46] Final Results from a Phase 2 Study of Pracinostat in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    Garcia-Manero, Guillermo
    Atallah, Ehab
    Khaled, Samer K.
    Arellano, Martha
    Patnaik, Mrinal M.
    Butler, Todd A.
    Ashby, Carla
    Medeiros, Bruno C.
    BLOOD, 2015, 126 (23)
  • [47] The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study
    Tan, Peter
    Tiong, Ing Soo
    Fleming, Shaun
    Pomilio, Giovanna
    Cummings, Nik
    Droogleever, Mark
    McManus, Julie
    Schwarer, Anthony
    Catalano, John
    Patil, Sushrut
    Avery, Sharon
    Spencer, Andrew
    Wei, Andrew
    ONCOTARGET, 2017, 8 (32) : 52269 - 52280
  • [48] Pevonedistat plus belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome: A phase I multicenter study
    Maher, Keri Renee
    Schafer, Danielle
    Schaar, Dale
    Sabo, Roy
    Bandyopadhyay, Dipankar
    Grant, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome
    Maher, Keri R.
    Shafer, Danielle
    Schaar, Dale
    Bandyopadhyay, Dipankar
    Deng, Xiaoyan
    Wright, John
    Piekarz, Richard
    Rudek, Michelle A.
    Harvey, R. Donald
    Grant, Steven
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [50] A Phase II Study of Azacitidine and Venetoclax as Maintenance Therapy in Patients With Acute Myeloid Leukemia
    Bazinet, Alexandre
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Alvarado, Yesid
    Chien, Kelly
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas
    Daver, Naval
    Issa, Ghayas
    Jain, Nitin
    Bull-Linderman, Debra
    DiNardo, Courtney
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S239 - S240
12345